| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C19H23NO |
| Molar mass | 281.399 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Propallorphan also known by numerous code names, some of the most prominent being RO-1-7780 (RO-7780) and NIH 6045, MCL-117 is an experimental drug of the substituted morphinan family that acts as an opioid antagonist.
Propallorphan has long been studied as an opioid (i.e., narcotic) antagonist, as confirmed by a 1956 study in which it was first described as RO-1-7780 and was shown to antagonize alphaprodine or morphine in dogs, and alphaprodine in humans. Simultaneous administration of RO-1-7780 with alphaprodine at a dose of 1/75 or 1/100 of the latter appeared to completely reverse the respiratory depression induced in dogs by the narcotic alone. At the same dose ratios of RO-1-7780 to alphaprodine in humans, the antagonist reduced the severity of alphaprodine-induced respiratory depression, while the overall narcotic effect was otherwise considered unchanged. Furthermore, a 1962 study reports that RO-1-7780 reverses the respiratory depressant effects of codeine, although twice the dose is required to achieve the same effect as levallorphan.
In a 1966 study, it was investigated alongside the known opioid antagonist nalorphine as a supplement to thiopental and nitrous oxide anesthesia. RO-1-7780 did not produce the marked respiratory depression observed following morphine administered in the same manner and at the same dose of 1.0 mg/kg. Propallorphan is much weaker in analgesia than the related compound levorphanol; its analgesic activity showed an EC50 of 38.9 mg/kg, with a duration of effect of 226 minutes. Propallorphan acts as a hallucinogen, as evidenced by the fact that its levorotatory isomer induces dysphoria and hallucinations—indeed, producing dysphoric and hallucinogenic effects comparable in intensity to those of nalorphine.

Propallorphan shares the tetracyclic ring skeleton of morphinan and a phenolic hydroxyl group at C-3 with levorphanol and levallorphan. The three compounds differ only in the substituent attached to the ring nitrogen atom at position-17. This group is methyl in levorphanol, allyl in levallorphan, and propargyl in propallorphan.